Recently, Janakiraman et al. determined that inhibition of COX-2 via celecoxib promoted apoptosis in paclitaxel-resistant oral cancer cells, both in vitro and in vivo. This evidence concerns the gene PTGS2 and lip and oral cavity carcinoma.